Oral semaglutide (Rybelsus) It is the first oral FDA-approved GLP-1 receptor agonist that maintains low blood sugar for patients with type 2 diabetes in combination with diet and exercise
For lupus patients who may already experience gastrointestinal symptomseither from the disease itself or from medications like NSAIDs or immunosuppressantsthese additional effects could be particularly troublesome and may affect medication adherence or nutritional status
Contacte a su proveedor de atencin mdica si esto ocurre, especialmente si experimenta sntomas inusuales
Its central nervous system mechanism avoids GI effects almost entirely, substituting them for mild insomnia, dry mouth, and occasional dizziness
This hormone helps regulate blood sugar, slow digestion, and reduce appetite, all of which can lead to weight loss
This level of weight loss is not only impressive but also meaningful in reducing the risks associated with obesity, such as heart disease, diabetes, and joint problems